| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
VisionWave Holdings Inc. (NASDAQ:VWAV) ("VisionWave" or the "Company") today announced the exercise of 403,620 common-stock purchase warrants at an exercise price of $11.50 per share, generating gross proceeds of approximately $4.64 million.
This new capital further strengthens VisionWave's balance sheet and enhances liquidity as the Company continues to advance its defense-technology programs. The funds are expected to be received on or about October 27, 2025, under our transfer agent's settlement schedule covering the period October 17–23, 2025.
The warrant exercises follow VisionWave's recent dual validation milestones — inclusion in the S&P Total Market Index and attainment of a 5/5 Technical Attribute rating from Nasdaq Dorsey Wright, as highlighted by Vanderbilt Report on October 21, 2025. Together, these developments underscore the Company's growing institutional footprint, market strength, and financial independence.
Management believes the combined effect of capital inflow and institutional recognition positions VisionWave among the most technically validated emerging defense-AI equities on Nasdaq. The Company's ability to attract capital through warrant exercises, without new equity issuance, reflects shareholder confidence in its execution strategy and reduces reliance on existing equity-line facilities, aligning with management's objective of minimizing dilution.
Posted In: VWAV
